Tumor Marker in Primary Lung Cancer
|
Accession number;04A0894545
|
| Title;Tumor Marker in Primary Lung Cancer |
| Author;
SUGIO KENJI
(Univ. of Occup. and Environ. Health)
SUGAYA MASAKAZU
(Univ. of Occup. and Environ. Health)
HANAGIRI TAKESHI
(Univ. of Occup. and Environ. Health)
YASUMOTO KOSEI
(Univ. of Occup. and Environ. Health)
|
Journal Title;J UOEH Occup Environ Health
|
Journal Code:Z0840A
|
ISSN:0387-821X
|
|
VOL.26;NO.4;PAGE.473-479(2004)
|
| Figure&Table&Reference;FIG.3, TBL.2, REF.10 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;Serum tumor markers are non-invasive diagnostic tools for malignant tumor and commonly used for screening of cancer and as an indicator of treatment-effect. In small cell lung cancer, NSE and proGRP are effective markers. In non-small cell lung cancer (NSCLC), CEA, SCC, CYFRA21-1, SLX and CA19-9 are commonly used for screening, and at least one marker among CEA, SCC or CYFRA21-1 is positive in 77% of patients with NSCLC. According to the histological type, the positive rate of CEA and CYFRA21-1 is high in adenocarcinoma patients, and the positive rate of CYFRA21-1 and SCC is high in squamous cell carcinoma patients. This review summarizes the clinical usefulness of tumor markers in primary lung cancer. (author abst.) |
|
|
|
Related Articles;
|
|
|
